ONMD ONEMEDNET CORP

OneMedNet Joins ClinEco Community of Clinical Research Industry Members

OneMedNet Joins ClinEco Community of Clinical Research Industry Members

~ Validates OneMedNet’s Regulatory Grade Real World Data Platform Among the Clinical Trial Eco-System ~

MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of precision curated regulatory-grade Real World Data (“RWD”), today announced that it has accepted an invitation to join ClinEco Inc., a connectivity platform and community environment, which improves access and expands distribution while promoting streamlined partner interactions and accelerated clinical innovation.

“We are excited to be invited to join this vibrant clinical trial community, which validates that our Real World Data platform is a trusted source for precision regulatory grade clinical data (RWD),” stated Aaron Green, OneMedNet President and CEO. “The effective utilization of Real World Data in clinical research is rapidly increasing and, as with many high growth market segments, there is a need for all participants to connect and grow together. We believe ClinEco will be a valuable platform for us to both educate, and efficiently provide specific and precise high quality RWD driving insights for Life Science members.”

ClinEco (short for Clinical Ecosystem) is the world’s first B2B market network for clinical trials, uniting sponsors, CROs, service providers, and sites on the world’s largest clinical trial marketplace enabling members to explore, engage, and exchange capabilities with their own ecosystem of partners. ClinEco was designed by the creators of SCOPE (Summit for Clinical Ops Executives).

About OneMedNet Corporation

Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical data repositories of healthcare providers. OneMedNet's robust iRWD™ platform provides secure, comprehensive management of diverse clinical data types, including electronic health records (EHR), laboratory results, medical imaging data. Employing its proven OneMedNet iRWD platform, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to healthcare providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements.

The OneMedNet iRWD network consists of 290+ facilities from leading healthcare systems and providers. Our commitment to growing our platform to provide near real time real-world data translates into healthcare innovations, setting new standards in patient care and advancing the future of medicine. For more information about OneMedNet Corporation, please visit .

About ClinEco

ClinEco unites sponsors, CROs, service providers, and sites on the world's first B2B clinical trial marketplace, empowering all to expand clinical partnerships. By creating a platform where all research stakeholders can explore, engage, and exchange capabilities with an ecosystem of partners, ClinEco accelerates the process of vendor selection, leading to faster, more efficient clinical trials. ClinEco is a Cambridge Healthtech Institute Company. Learn more about the ClinEco community by visiting .

Company Contact:

OneMedNet Corporation

Michael Wong, Director of Marketing

Phone: 800.918.7189

Email:

SOURCE: ONEMEDNET CORPORATION



EN
30/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONEMEDNET CORP

 PRESS RELEASE

OneMedNet Announces Next Phase of Commercial Launch with its Real-Worl...

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry MINNEAPOLIS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced the next phase of commercial launch with its RWD Platform powered by Palantir Foundry. Following the successful November 10, 2025, demonstration of live feeds, subscription access, and AI-driven search at major tradeshows, the Company is actively c...

 PRESS RELEASE

OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale,...

OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic partnership with ViuHealth, a digital health company specializing in autoimmune disease populations. This partnership expands OneMedNet’s autoimmune clinical ontology, to the OneMedNet iRWD™ platform—powered by Palantir Foundry—further increasing the scale, diversity, an...

 PRESS RELEASE

OneMedNet Announces Strategic Neuro Data Partnership with Risorius to ...

OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a neurotechnology company developing EEG-based digital biomarkers and AI-powered research platforms for central nervous system (CNS) indications across neurology, psychiatry, and sleep. This new relationship supports OneMedNet’s continued focus on expan...

 PRESS RELEASE

OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Pr...

OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Prior Year by More Than 4.1X and Accelerating Subscription Transition MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), today announced record bookings in 2025 of data-delivery agreements totaling $2.79 million of contract value, exceeding 2024 bookings by more than four times (4X). The milestone reflects increasing deal size, strong enterprise demand, and meaningful progress toward a recurring...

 PRESS RELEASE

OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered ...

OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered Scaida BrainCT-ICH Software MINNEAPOLIS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced that its high-quality, multimodal clinical data supported mlHealth 360 in obtaining U.S. Food and Drug Administration (FDA) 510(k) clearance for Scaida BrainCT-ICH, an AI-powered software solution designed to facilitate the rapid detection of intracranial hemorrhage (ICH) from head computed tomography (CT) scans. Scaida B...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch